Intrexon Corporation
0 DAYS LEFT TO SEEK LEAD PLAINTIFF STATUS
Case Summary | |
Company Name: | Intrexon Corporation |
Stock Symbol : | NYSE: XON |
Class Period Start: | 05/12/2015 |
Class Period End: | 04/20/2016 |
Lead Plaintiff motion: | 07/05/2016 |
Date Filed: | 05/03/2016 |
Type of Case: | Securities Class Action |
Court: | U.S. District Court for the Northern District of California |
Summary: | Thieler Law Corp advises investors with losses exceeding $100,000 of the July 5, 2016 lead plaintiff deadline in a class action lawsuit filed against Intrexon Corporation (NYSE: XON) (“Intrexon” or “the Company”). The suit is pending in the U.S. District Court for the Northern District of California and investors, who purchased Intrexon Corporation securities between May 12, 2015 and April 20, 2016, have until July 5, 2016 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class. If you purchased Intrexon Corporation securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class. The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that Intrexon was overstating its revenue; and as a result, Defendants’ statements about Intrexon’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. On April 21, 2016, a report was published alleging that Intrexon technology has recently been questioned by officials from the World Health Organization, the Centers for Disease Control and Prevention, and the National Institutes of Health. The report also alleged that Intrexon overstated revenues by 50% through transactions with related parties; Intrexon’s technology platform is an overhyped, undifferentiated collection of commodity and failed products; and Intrexon is the Theranos of the public markets. Following this news, NYSE: XON shares dropped more than 26% on April 21, 2016. If you were negatively impacted by your investment in Intrexon Corporation securities between May 12, 2015 and April 20, 2016 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation. Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Thieler Law Corp 2534 State Street - Suite 406, San Diego, CA 92101 by email: mail@thielerlaw.com or telephone at +1 (619) 377 - 4324 or visit our website http://www.thielerlaw.com/ or Facsimile: +1 (619) 785 – 3185 |